Karin Riedl

IC31® and IC30, novel types of vaccine adjuvant based on peptide delivery systems

K. Lingnau, A. von Gabain, Karin Riedl, 2007, Expert review of vaccines.

Adjuvating the adjuvant: facilitated delivery of an immunomodulatory oligonucleotide to TLR9 by a cationic antimicrobial peptide in dendritic cells.

G. Schütz, Julian Weghuber, Lars Zimmermann, 2011, Vaccine.

The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.

R. Riedl, K. Lingnau, E. Nagy, 2008, Vaccine.

The Two-Component Adjuvant IC31® Boosts Type I Interferon Production of Human Monocyte-Derived Dendritic Cells via Ligation of Endosomal TLRs

A. Bácsi, A. Szabo, P. Gogolák, 2013, PloS one.